This disclosure relates to electrodes for medical implants.
It is not uncommon for a patient to experience partial hearing loss (for example due to damage to only a portion of the hair cells), and to retain some residual hearing. In such cases, if surgery to treat the partial hearing loss is performed, there is an accompanying risk that the residual hearing is negatively affected as a result of the surgery.
For example, physical damage may be caused to healthy tissue during the implantation process, or the mere presence of a foreign object in the cochlea may affect the dynamics of the hearing process. In the case of a cochlear implant in which an electrode is inserted into the cochlea of a patient, a short electrode may be implanted to replace the function of the damaged hair cells, but leave the unaffected hair cells (usually an apical portion). The mere presence of the short electrode in the scala tympani can, however, affect the distribution of energy generated by external sounds to the healthy hair cells.
Existing methods and implants attempt to address this problem by reducing the lateral cross-sectional area of the electrode to minimize disruption. Even a smaller electrode still interferes with a natural function of the cochlea.
According to one aspect of the present disclosure, there is provided an electrode for a cochlear implant for implantation in a cochlea of a patient, the electrode comprising an electrode contact side for supporting at least one electrode contact and a fluid contact side for exposure to fluid in the cochlea, wherein, the electrode contact side is curved in a lateral dimension so as to substantially conform to a wall of the cochlea upon implantation, and wherein the electrode is non-circular in cross section so as to maximize a naturally occurring cross-sectional fluid-flow area in the cochlea, minimizing disruption.
In one form, the fluid contact side is concave in cross section. In one form, the cross section is substantially oval. In one form, the cross section is substantially semi-circular. According to another aspect of the present disclosure, there is provided an electrode for a cochlear implant for implantation in a cochlea of a patient, wherein the electrode is shaped such that for a given cross-sectional area, the electrode, when implanted into the cochlea, provides for a more natural fluid-flow cross-sectional area in the cochlea than if the electrode were substantially circular in cross section.
The various aspects of the present disclosure are described in detail below, with reference to the following drawings in which:
FIG. 1—shows a graph of the velocity of fluid within a channel as a function of its distance from a wall of the channel;
FIG. 2A—shows the effective cross section of the scala tympani in a cochlea using a conventional electrode;
FIG. 2B—shows the corresponding effective cross section of the scala tympani in the cochlea using an electrode according to one aspect of the present disclosure;
FIG. 3—shows an electrode according to an aspect of the present disclosure located (perimodiolar) in the scala tympani of a cochlea;
FIG. 4—shows the arrangement of
FIG. 5—shows a “symmetrical” embodiment of the electrode of
FIG. 6—shows an embodiment of the electrode of
FIG. 7—shows an electrode having an elliptical configuration;
FIG. 8—shows an electrode having a modified elliptical configuration;
FIG. 9—shows an electrode having another modified elliptical configuration;
FIG. 10—shows a conventional circular non-perimodiolar electrode;
FIG. 11—shows a non-perimodiolar electrode according to one aspect of the present disclosure;
FIG. 12—shows a non-perimodiolar electrode design according to one aspect of the present disclosure;
FIG. 13—shows an alternative non-perimodiolar electrode design to that of
FIG. 14—shows an elliptical non-perimodiolar electrode design;
FIG. 15—shows an alternative non-perimodiolar electrode design;
FIG. 16—shows yet a further alternative non-perimodiolar electrode design;
FIGS. 17A-17D—show an electrode as it traverses across the scala tympani;
FIGS. 18A-18F—show the change in effective cross-sectional area with change in the electrode cross sectional for a “winged” electrode shape;
FIGS. 19A-19F—show the change in effective cross-sectional area with change in the electrode cross sectional for a “symmetrical” electrode shape; and
FIG. 20—shows a perspective view of an electrode according to one aspect of the present disclosure, having a cross section as shown in
Throughout the following description, the phrase “cross section” will be used. It will be understood that “cross section” refers to the cross section taken substantially perpendicularly to the length of the electrode or the length of the scala tympani or other channel of the cochlea or other vessel such as a blood vessel, vein, or artery.
The term “effective cross-sectional area” as used in this specification is the area that remains in the cochlea, with the electrode in situ, that is available for free and natural movement of cochlear fluid. This may be represented in the figures by a circle, oval, or maximum-sized regular closed curve in the cross-sectional area that remains in the cochlea with the electrode in situ. The shape and cross-sectional area of the effective cross-sectional area (e.g., after implantation) of a particular portion of the cochlea, in comparison to the shape and cross-sectional area of that same portion before implantation, at least partially determines how much of the anatomical acoustic pathway is retained after implantation (and e.g., how “naturally” the fluid flows in the cochlea after implantation). While circles and ovals are used throughout the figures for ease of comparison purposes in relation to illustrating example effective cross-sectional areas, it should be understood that an effective cross-sectional area, in practice, may have a more irregular shape, and will be impacted by the shape of the cochlea and/or the electrode, among other things.
The word “traverse” in this specification is used to describe the region between the cochleostomy (or round window) and where the electrode becomes perimodiolar in the basal turn.
The design of the present disclosure, allows for an electrode that preserves residual hearing via a fundamentally different approach from that of the prior art. According to one aspect of the present disclosure, instead of focusing on reducing the negative impact of the electrode in the cochlear by simply decreasing the cross-sectional area of the electrode, the electrode of the present disclosure aims to instead focus on the shape and size of the effective cross-sectional fluid-flow area of the cochlea (e.g., relative to pre-implantation cross-sectional fluid-flow shape and size).
When a fluid flows through a pipe there are losses along the wall. The basic premise of pipe design is to maximize the volume and minimize the perimeter. There is effective friction on the perimeter of a pipe called a boundary layer. In the boundary layer the fluid flows at a lower velocity.
Movement within the fluid (perilymph) in the cochlea travels in the scala vestibuli to the helicotrema and down the scala tympani. This movement within the fluid moves the basilar membrane, Reissner's membrane, and tectorial. The tectorial membrane moves and touches the hair cells, resulting in cells firing and thus “hearing.”
The disclosed design allows fluid to move more naturally in the cochlea with the aim to keep residual hearing and provide for a more natural fluid-flow in the scala tympani after implantation relative to the fluid-flow prior to implantation.
A common complaint from recipients is that the sound they receive after an implant is tinnier (i.e., the sounds are of a higher frequency than they are used to). This is because, after an insertion of an electrode, the perceived hearing frequencies shift. This shift is caused by the impact of having an electrode occupying space in the cochlea that was previously empty. The electrode's presence causes a reduction in the effective cross-sectional area of the cochlea and, due to the circular shape of prior electrodes, a change in shape of the effective cross-sectional area. Natural sound (residual hearing) is still inputted to the patient having the same energy. The same energy with a smaller cross section and/or different shape results in a different wave frequency, resulting in stimulation at a different position(s) along the cochlea. Thus, according to this aspect of the disclosure, focus is placed on providing a more natural fluid-flow in the channel, rather than simply on reducing the cross-sectional area of the electrode. This is a significant departure from the prior art methods and designs of simply attempting to reduce the cross-sectional area of the electrode, without consideration of changes in pre- and post-implantation fluid flow characteristics in the channel.
Thus, in this aspect, the electrode design may maintain a same or similar physical cross-sectional area and thus amount of material (e.g., wire diameter and silicone volume required for shape retention) as before, but optimizes the size and shape of the effective cross-sectional area in the cochlea for fluid flow.
Referring to
Even as manufacturing methods improve and the volume of components required decreases, this improved design still allows for an electrode that provides the same functionality but that further increases the effective area in the cochlea for fluid flow and provides for more natural fluid-flow characteristics relative to fluid-flow characteristics of the cochlea prior to implantation.
This design may be used in any existing electrode configuration, including a Hybrid device, that is, one that has the electrode for cochlea stimulation and another means to facilitate residual hearing.
In one aspect of this design, for a perimodiolar electrode, the electrode is not only in gentle contact with the inner wall, but also the upper and lower walls.
A number of different variations according to this aspect of the present disclosure are described with reference to
The electrode in
Table 1 below shows a comparison of the change in effective cross-sectional area using a “winged” substantially crescent-shaped configuration as compared to a circular configuration of the same cross-sectional area.
In each of the above
Table 2 and
These calculations may be made using any suitable techniques for calculating areas of geometric shapes including using well known formulae or commercially-available software CAD or other packages.
In each of the above
The various aspects of the present disclosure may also be applied to non-perimodiolar, or straight electrodes (in that they are pre-disposed to a straight shape and the cochlear forces them to curve and the placement is thus on the outer wall of the scala tympani).
One advantage of the straight electrode design is that the cross section can be more easily tailored (i.e., made symmetrical) to facilitate large effective cochlea areas without siding the electrode (i.e., requiring a different electrode for left or right cochleas).
The non-perimodiolar design is also applicable to various elliptical configurations as shown in
According to a further aspect of the present disclosure, the various principles described herein may also be applied to the traverse of the electrode between cochleostomy and the start of the perimodiolar portion of the electrode in the basal turn. This design avoids blocking of the cochlea duct and thus allows for improved fluid flow in the channel.
Traditionally, cochleostomies are placed on the lateral wall. If a full flow characteristic is to be maintained then the electrode would need to cross the cochlear duct to the modiolar wall without disrupting the channel. This may be done by travelling on the scala tympani floor until the modiolar wall is reached.
The preservation of residual hearing is assisted by the present disclosure through keeping the basal turn clear for fluid flow. In conventional designs, perimodiolar electrodes travel from the cochleostomy to the inner wall and in doing so, block the fluid flow across the traverse. The portion of the electrodes travelling across this traverse are typically at their largest diameter in this region.
A pre-curved electrode has a minimum volume required to maintain shape. There is no requirement for shape retention across the traverse (electrode typically straight). As a further alternative, the electrode can be reduced in diameter across this region and thus facilitate fluid flow.
It will be understood that the above has been described with reference to particular embodiments and that many variations and modifications may be made within the scope of the different aspects of the present disclosure.
For example the various aspects of the present disclosure are equally applicable to electrodes and leads for medical implants other than cochlear implants.
Throughout the specification and the claims that follow, unless the context requires otherwise, the words “comprise” and “include” and variations such as “comprising” and “including” will be understood to imply the inclusion of a stated integer or group of integers, but not the exclusion of any other integer or group of integers.
The reference to any prior art in this specification is not, and should not be taken as, an acknowledgement of any form of suggestion that such prior art forms part of the common general knowledge.
Number | Date | Country | Kind |
---|---|---|---|
2008904057 | Aug 2008 | AU | national |
The present application is a continuation of PCT/AU2009/000871, filed on Jul. 7, 2009, and claims priority to Australian Patent Application AU 2008904057, filed in the Australian Patent Office on Aug. 8, 2008, the entire contents of both of which are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
Parent | PCT/AU2009/000871 | Jul 2009 | US |
Child | 13023287 | US |